NDC 60505-5306-01 - acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-5306
- Requested NDC
- 60505-5306-01
- Package NDCs from labels
- 60505-5306-3, 60505-5306-1, 60505-5306-5, 60505-5306-8, 60505-5306-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-06-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACYCLOVIR TABLETS, USP 400 mg and 800 mg | REMEDYREPACK INC. | 2026-06-26 | HUMAN PRESCRIPTION DRUG LABEL |
| ACYCLOVIR TABLETS, USP 400 mg and 800 mg | Apotex Corp. | Apotex Inc. | 2025-11-20 | HUMAN PRESCRIPTION DRUG LABEL |
| acyclovir - Major Pharmaceuticals | Major Pharmaceuticals | 2025-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - American Health Packaging | American Health Packaging | 2024-12-06 | HUMAN PRESCRIPTION DRUG LABEL |
| ACYCLOVIR TABLETS, USP 400 mg and 800 mg | NuCare Pharmaceuticals,Inc. | 2024-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
| ACYCLOVIR TABLETS, USP 400 mg and 800 mg | NuCare Pharmaceuticals,Inc. | Apotex Inc. | 2024-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
| ACYCLOVIR TABLETS, USP 400 mg and 800 mg | Preferred Pharmaceuticals, Inc. | 2023-03-01 | HUMAN PRESCRIPTION DRUG LABEL |
| acyclovir - RedPharm Drug | EPM Packaging | RedPharm Drug | EPM Packaging | 2023-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
| acyclovir - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2023-01-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Lake Erie Medical DBA Quality Care Products LLC | Lake Erie Medical DBA Quality Care Products LLC | 2022-11-08 | HUMAN PRESCRIPTION DRUG LABEL |
| acyclovir - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2022-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| ACYCLOVIR TABLETS, USP 400 mg and 800 mg | Golden State Medical Supply, Inc. | 2021-03-24 | HUMAN PRESCRIPTION DRUG LABEL |
| acyclovir - A-S Medication Solutions | A-S Medication Solutions | 2021-03-17 | HUMAN PRESCRIPTION DRUG LABEL |
| ACYCLOVIR TABLETS, USP 400 mg and 800 mg | NuCare Pharmaceuticals,Inc. | 2021-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
| acyclovir - Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2020-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
| acyclovir - A-S Medication Solutions | A-S Medication Solutions | 2020-05-29 | HUMAN PRESCRIPTION DRUG LABEL |
| acyclovir - Proficient Rx LP | Proficient Rx LP | 2020-02-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-5306-1 | acyclovir | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 60505-5306-3 | acyclovir | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 60505-5306-5 | acyclovir | 500 in 1 BOTTLE | TABLET | 500 | 7 | |
| 60505-5306-8 | acyclovir | 1000 in 1 BOTTLE | TABLET | 1000 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-5306 | ACYCLOVIR TABLET [APOTEX CORP.] | 6 | Current NDC, Legacy NDC, 4 package rows | 20240425_7fdeb609-24c4-5024-52c3-6a32bc7f3fcc.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-5306-1 | EA - Each | 60505-5306 | 63f2f8bd-5cf3-4d15-8377-3520d0fc587d | 1 | 2012-07-24 |
| 60505-5306-8 | EA - Each | 60505-5306 | 48317053-5167-4156-824f-60fc8e1781ed | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc | 75334fc5-d236-401a-875c-f4f9c7749c1a | 2026-01-19 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| DENTI BUONGIORNO PLAQUE CARE LEMON MINT TOOTH | SILICA, SODIUM FLUORIDE, TOCOPHERYL ACETATE, TETRASODIUM PYROPHOSPHATE | ATOSAFE CO., Ltd | 487c5036-0eb0-ada9-e063-6394a90aa02e | 2026-01-16 | Warnings | ETJ7Z6XBU4 |
| DENTI BUONGIORNO PLAQUE CARE LEMON MINT TOOTH | SILICA, SODIUM FLUORIDE, TOCOPHERYL ACETATE, TETRASODIUM PYROPHOSPHATE | DONG IL PHARMS CO.,LTD | 487cd5b9-28f3-392d-e063-6394a90a9ba1 | 2026-01-16 | Warnings | ETJ7Z6XBU4 |
| DENTI BUONGIORNO GUM CARE COOL MINT TOOTH | SILICA, SODIUM FLUORIDE, TOCOPHERYL ACETATE | ATOSAFE CO., Ltd | 487cf27a-d761-6353-e063-6394a90af029 | 2026-01-16 | Warnings | ETJ7Z6XBU4 |
| DENTI BUONGIORNO FRESH BREATH HERB MINT TOOTH | SILICA, SODIUM MONOFLUOROPHOSPHATE | ATOSAFE CO., Ltd | 487d52d1-8853-bc90-e063-6394a90ab91d | 2026-01-16 | Warnings | ETJ7Z6XBU4 |
| DENTI BUONGIORNO GUM CARE COOL MINT TOOTH | SILICA, SODIUM FLUORIDE, TOCOPHERYL ACETATE | DONG IL PHARMS CO.,LTD | 487d689d-ebdd-43c3-e063-6294a90af0e2 | 2026-01-16 | Warnings | ETJ7Z6XBU4 |
| DENTI BUONGIORNO FRESH BREATH HERB MINT TOOTH | SILICA, SODIUM MONOFLUOROPHOSPHATE | DONG IL PHARMS CO.,LTD | 487da363-1d01-8cdc-e063-6294a90ac24d | 2026-01-16 | Warnings | ETJ7Z6XBU4 |
| Berberis Quartz | BERBERIS QUARTZ | Uriel Pharmacy Inc. | 5da48d70-1140-495d-b672-0e55c04196e1 | 2026-01-16 | Warnings | ETJ7Z6XBU4 |
| acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc | c11c1136-7421-48ff-86d2-39507e80a04c | 2026-01-15 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc. | b1033fda-8242-4006-b1cd-23474d70671f | 2026-01-15 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Constipation Relief | ALUMINUM OXIDE, BRYONIA ALBA ROOT, SODIUM CHLORIDE, GRAPHITE, SILICON DIOXIDE | Homeocare Laboratories | 62374240-cd14-44e2-9405-5f8996faf047 | 2026-01-12 | Warnings | ETJ7Z6XBU4 |
| Menopause Relief | BARIUM CARBONATE, ATROPA BELLADONNA, BLACK COHOSH, NITROGLYCERIN, LACHESIS MUTA VENOM, SILICON DIOXIDE | Homeocare Laboratories | 99b182d5-4102-4b25-85d3-f4be077d753f | 2026-01-12 | Warnings | ETJ7Z6XBU4 |
| Amber Amethyst | AMBER AMETHYST | Uriel Pharmacy, Inc | 4837e805-a777-c1fa-e063-6294a90ae9c4 | 2026-01-12 | Warnings | ETJ7Z6XBU4 |
| ECHINACEA | ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS | Marco Pharma International LLC. | 7efadb70-99e4-428b-a8ef-a2797327c6fa | 2026-01-12 | Warnings | ETJ7Z6XBU4 |
| RET Stomach 7001 | RET STOMACH | Professional Complementary Health Formulas | 086427e0-599e-4405-a996-d949023f9d90 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Organophosphate Combination 9309 | ORGANOPHOSPHATE COMBINATION | Professional Complementary Health Formulas | f777015f-1df6-4821-af63-543175313aba | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Low Vaccinosis Nosode 4024 | LOW VACCINOSIS NOSODE | Professional Complementary Health Formulas | f347ac8f-ac05-46ef-91a3-9f7e00034768 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| First Chakra (Root) 7301 | FIRST CHAKRA (ROOT) | Professional Complementary Health Formulas | 61eb1bbe-6675-4369-b852-18975e6b08c7 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Second Chakra (Sacral) 7302 | SECOND CHAKRA (SACRAL) | Professional Complementary Health Formulas | ea8a69d3-66fc-4b21-bfdd-c207dd293589 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Silicea 8012 | SILICEA | Professional Complementary Health Formulas | a2a1eae8-24c8-44dd-9b9d-1826fa716433 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.